Greenwood Capital Associates’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-17,395	Closed	-$256K	–	251
2023 Q4	$256K	Buy	17,395 +43	+0.2%	+$633	0.03%	233
2023 Q3	$318K	Buy	+17,352	New	+$318K	0.05%	220